Back to Search
NATHANIEL BROWNLOW, MD
MD
Family Medicine Physician
NPI: 1447225891Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
209405(NY)
Research & Publications (5)
Protein kinase C epsilon in cell division: control of abscission.
PMID 19197162·Cell Cycle·2009
7-preclinical
Dasatinib is a potent inhibitor of tumour-associated macrophages, osteoclasts and the FMS receptor.
PMID 18784745·Leukemia·2009
7-preclinical
Tandutinib inhibits FMS receptor signalling, and macrophage and osteoclast formation in vitro.
PMID 18185521·Leukemia·2008
7-preclinical
Comparison of nilotinib and imatinib inhibition of FMS receptor signaling, macrophage production and osteoclastogenesis.
PMID 17851554·Leukemia·2008
4-observational
FMS receptor for M-CSF (CSF-1) is sensitive to the kinase inhibitor imatinib and mutation of Asp-802 to Val confers resistance.
PMID 16170366·Oncogene·2006
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 247 3RD AVE RM 403
NEW YORK, NY 10010 - Phone
- (212) 533-2099
Quick Facts
- NPI
- 1447225891
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile